The presence of hyopmagnesemia related to the secondary hyperaldosteronism of cirrhosis was confirmed in 15 children and adolescents. Normomagnesemic levels returned in 6 of 7 patients treated with an aldosterone antagonist. The implications of such a response to therapy and of the progression from normal to low serum magnesium levels are discussed.
|Original language||English (US)|
|Number of pages||3|
|Journal||The Journal of Pediatrics|
|State||Published - Mar 1970|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health